424 related articles for article (PubMed ID: 17651955)
1. Immune system recognition of Trypanosoma cruzi.
Tarleton RL
Curr Opin Immunol; 2007 Aug; 19(4):430-4. PubMed ID: 17651955
[TBL] [Abstract][Full Text] [Related]
2. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.
Koga R; Hamano S; Kuwata H; Atarashi K; Ogawa M; Hisaeda H; Yamamoto M; Akira S; Himeno K; Matsumoto M; Takeda K
J Immunol; 2006 Nov; 177(10):7059-66. PubMed ID: 17082622
[TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
[TBL] [Abstract][Full Text] [Related]
4. Vaccination approaches against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Malchiodi EL
Expert Rev Vaccines; 2009 Jul; 8(7):921-35. PubMed ID: 19538117
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
Campos MA; Gazzinelli RT
Mediators Inflamm; 2004 Jun; 13(3):139-43. PubMed ID: 15223603
[TBL] [Abstract][Full Text] [Related]
6. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family.
Santos MA; Garg N; Tarleton RL
Mol Biochem Parasitol; 1997 May; 86(1):1-11. PubMed ID: 9178263
[TBL] [Abstract][Full Text] [Related]
7. [Host immune response to Trypanosoma cruzi and its evasion mechanism].
Yamamoto M; Takeda K
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1053-8. PubMed ID: 21089540
[No Abstract] [Full Text] [Related]
8. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
Miyahira Y
Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses.
Almeida IC; Gazzinelli RT
J Leukoc Biol; 2001 Oct; 70(4):467-77. PubMed ID: 11590183
[TBL] [Abstract][Full Text] [Related]
10. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi.
Diez H; López MC; Del Carmen Thomas M; Guzmán F; Rosas F; Velazco V; González JM; Puerta C
Parasite Immunol; 2006 Mar; 28(3):101-5. PubMed ID: 16441508
[TBL] [Abstract][Full Text] [Related]
12. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
13. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.
Martin D; Tarleton R
Immunol Rev; 2004 Oct; 201():304-17. PubMed ID: 15361249
[TBL] [Abstract][Full Text] [Related]
14. The innate immune response to Trypanosoma cruzi infection.
Kayama H; Takeda K
Microbes Infect; 2010 Jul; 12(7):511-7. PubMed ID: 20348008
[TBL] [Abstract][Full Text] [Related]
15. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S
Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126
[TBL] [Abstract][Full Text] [Related]
17. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
Basso B; Marini V
Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
[TBL] [Abstract][Full Text] [Related]
18. Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection.
Bustamante J; Tarleton R
Mem Inst Oswaldo Cruz; 2015 May; 110(3):445-51. PubMed ID: 25946159
[TBL] [Abstract][Full Text] [Related]
19. Macrophages in experimental Chagas' disease.
Kuhn RE
Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
[TBL] [Abstract][Full Text] [Related]
20. Parasite cysteine proteinase interactions with alpha 2-macroglobulin or kininogens: differential pathways modulating inflammation and innate immunity in infection by pathogenic trypanosomatids.
Scharfstein J
Immunobiology; 2006; 211(1-2):117-25. PubMed ID: 16446176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
